294 related articles for article (PubMed ID: 34350721)
1. A vaccination update for rheumatologists-SARS-CoV-2, influenza and herpes zoster.
Wong PKK; Lahiri M; Lye DC; Johnson D; Charles PGP
Int J Rheum Dis; 2021 Aug; 24(8):979-983. PubMed ID: 34350721
[No Abstract] [Full Text] [Related]
2. Vaccines and Disease-Modifying Antirheumatic Drugs: Practical Implications for the Rheumatologist.
Friedman MA; Winthrop KL
Rheum Dis Clin North Am; 2017 Feb; 43(1):1-13. PubMed ID: 27890167
[TBL] [Abstract][Full Text] [Related]
3. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.
Furer V; Rondaan C; Heijstek MW; Agmon-Levin N; van Assen S; Bijl M; Breedveld FC; D'Amelio R; Dougados M; Kapetanovic MC; van Laar JM; de Thurah A; Landewé RB; Molto A; Müller-Ladner U; Schreiber K; Smolar L; Walker J; Warnatz K; Wulffraat NM; Elkayam O
Ann Rheum Dis; 2020 Jan; 79(1):39-52. PubMed ID: 31413005
[TBL] [Abstract][Full Text] [Related]
4. Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases.
Friedman MA; Curtis JR; Winthrop KL
Ann Rheum Dis; 2021 Oct; 80(10):1255-1265. PubMed ID: 34493491
[TBL] [Abstract][Full Text] [Related]
5. Herpes zoster infection, vaccination and immunocompromised rheumatology patients.
O'Connor MB; Phelan MJ
Rheumatol Int; 2013 Jan; 33(1):239-40. PubMed ID: 21947348
[TBL] [Abstract][Full Text] [Related]
6. Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases.
Spiera R; Jinich S; Jannat-Khah D
Ann Rheum Dis; 2021 Oct; 80(10):1357-1359. PubMed ID: 33975857
[No Abstract] [Full Text] [Related]
7. COVID-19 and rheumatology: Reflecting on the first wave and preparing for the second wave.
Fardanesh A; Byravan S; Moorthy A; Tahir H
Int J Rheum Dis; 2021 Jan; 24(1):7-9. PubMed ID: 33459529
[No Abstract] [Full Text] [Related]
8. SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response.
Bonelli MM; Mrak D; Perkmann T; Haslacher H; Aletaha D
Ann Rheum Dis; 2021 Oct; 80(10):1355-1356. PubMed ID: 33958323
[No Abstract] [Full Text] [Related]
9. Immunogenicity and safety of zoster vaccine live administered with quadrivalent influenza virus vaccine.
Levin MJ; Buchwald UK; Gardner J; Martin J; Stek JE; Brown E; Popmihajlov Z
Vaccine; 2018 Jan; 36(1):179-185. PubMed ID: 28830693
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study.
Furer V; Eviatar T; Zisman D; Peleg H; Paran D; Levartovsky D; Zisapel M; Elalouf O; Kaufman I; Meidan R; Broyde A; Polachek A; Wollman J; Litinsky I; Meridor K; Nochomovitz H; Silberman A; Rosenberg D; Feld J; Haddad A; Gazzit T; Elias M; Higazi N; Kharouf F; Shefer G; Sharon O; Pel S; Nevo S; Elkayam O
Ann Rheum Dis; 2021 Oct; 80(10):1330-1338. PubMed ID: 34127481
[TBL] [Abstract][Full Text] [Related]
11. High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases.
Ruddy JA; Connolly CM; Boyarsky BJ; Werbel WA; Christopher-Stine L; Garonzik-Wang J; Segev DL; Paik JJ
Ann Rheum Dis; 2021 Oct; 80(10):1351-1352. PubMed ID: 34031032
[No Abstract] [Full Text] [Related]
12. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.
Machado PM; Lawson-Tovey S; Strangfeld A; Mateus EF; Hyrich KL; Gossec L; Carmona L; Rodrigues A; Raffeiner B; Duarte C; Hachulla E; Veillard E; Strakova E; Burmester GR; Yardımcı GK; Gomez-Puerta JA; Zepa J; Kearsley-Fleet L; Trefond L; Cunha M; Mosca M; Cornalba M; Soubrier M; Roux N; Brocq O; Durez P; Conway R; Goulenok T; Bijlsma JW; McInnes IB; Mariette X
Ann Rheum Dis; 2022 May; 81(5):695-709. PubMed ID: 34972811
[TBL] [Abstract][Full Text] [Related]
13. Knowledge, attitudes, and clinical practice of rheumatologists in vaccination of the at-risk rheumatology patient population.
McCarthy EM; Azeez MA; Fitzpatrick FM; Donnelly S
J Clin Rheumatol; 2012 Aug; 18(5):237-41. PubMed ID: 22832287
[TBL] [Abstract][Full Text] [Related]
14. TNF antagonists and shingles: is vaccination advisable?
Nisar MK; Ostor AJ
Ann Rheum Dis; 2013 May; 72(5):e1. PubMed ID: 23456927
[No Abstract] [Full Text] [Related]
15. Modifications in Systemic Rheumatic Disease Medications: Patients' Perspectives During the Height of the COVID-19 Pandemic in New York City.
Mancuso CA; Duculan R; Jannat-Khah D; Barbhaiya M; Bass AR; Mandl LA; Mehta B
Arthritis Care Res (Hoboken); 2021 Jun; 73(6):909-917. PubMed ID: 33085850
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology.
Park JK; Lee EB; Shin K; Sung YK; Kim TH; Kwon SR; Lee MS; Hong SJ; Choi BY; Lee SS; Back HJ;
J Korean Med Sci; 2021 Mar; 36(12):e95. PubMed ID: 33783147
[TBL] [Abstract][Full Text] [Related]
17. Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2.
Braun-Moscovici Y; Kaplan M; Braun M; Markovits D; Giryes S; Toledano K; Tavor Y; Dolnikov K; Balbir-Gurman A
Ann Rheum Dis; 2021 Oct; 80(10):1317-1321. PubMed ID: 34144967
[TBL] [Abstract][Full Text] [Related]
18. Association study between herpes zoster reporting and mRNA COVID-19 vaccines (BNT162b2 and mRNA-1273).
Préta LH; Contejean A; Salvo F; Treluyer JM; Charlier C; Chouchana L
Br J Clin Pharmacol; 2022 Jul; 88(7):3529-3534. PubMed ID: 35174524
[TBL] [Abstract][Full Text] [Related]
19. Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugs.
Meroni PL; Zavaglia D; Girmenia C
Clin Exp Rheumatol; 2018; 36(2):317-328. PubMed ID: 29303710
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Prevention of Herpes Zoster Reactivation in Patients with Autoimmune Diseases.
Chakravarty EF
Rheum Dis Clin North Am; 2017 Feb; 43(1):111-121. PubMed ID: 27890168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
